Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04418453 · ClinicalTrials.gov registry record

Rural MOUD Telemedicine in Primary Care Phase 1

A clinical trial, sponsored by University of California, Los Angeles.

Completed
Registry status
36,762
Enrollment target

NCT04418453: Completed study, sponsored by University of California, Los Angeles.

NCT04418453 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 36,762 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04418453 has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
36,762 participants
Enrollment target

Study Summary

The feasibility study (Phase 1) will examine the implementation of telemedicine (TM) in six rural clinics in two states/regions with varying levels of OBOT capacity.

Primary Outcome

Number of days patients receive MOUD based on EHR data

Interventions

  • OTHER Integration of telemedicine for MOUD in primary care

Trial Details

FieldValue
Enrollment Target 36,762 participants
Start Date 2020-06-01
Est. Completion 2021-11-05

What the finished NCT04418453 record still lists

NCT04418453 is an observational study that tracks outcomes without assigning an intervention. Its 36,762 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Integration of telemedicine for MOUD in primary care is the first listed.

NCT04418453 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04418453 about?

NCT04418453 is a clinical study titled "Rural MOUD Telemedicine in Primary Care Phase 1". The feasibility study (Phase 1) will examine the implementation of telemedicine (TM) in six rural clinics in two states/regions with varying levels of OBOT capacity.

What is the current status of trial NCT04418453?

This trial is currently completed. The enrollment target is 36,762 participants. The study started on 2020-06-01. Estimated completion is 2021-11-05.

What interventions are being tested in trial NCT04418453?

The interventions under investigation include: Integration of telemedicine for MOUD in primary care (OTHER).

Who is sponsoring clinical trial NCT04418453?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07150923 · 36,503 participants · NA

    Supraglottic Airway for Resuscitation Trial

  • NCT05796505 · 37,122 participants · NA

    Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

  • NCT03262259 · 36,000 participants · NA

    Evaluation of Global Smart Drinking Goals Initiative

  • NCT02225301 · 35,000 participants · NA

    iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04418453, the US trial registry maintained by the National Library of Medicine. NCT04418453 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.